{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:20:00Z","timestamp":1767993600396,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR9624\/MED\/30\/1253\/2013"],"award-info":[{"award-number":["BT\/PR9624\/MED\/30\/1253\/2013"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.pbb.2018.11.009","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T05:46:22Z","timestamp":1543297582000},"page":"63-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Biological profiling of piperazinediones for the management of anxiety"],"prefix":"10.1016","volume":"176","author":[{"given":"Devendra","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukesh K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit","family":"Ganeshpurkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dileep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitul","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sairam","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2018.11.009_bb0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.brainres.2017.12.011","article-title":"Anxiolytic- and antidepressant-like actions of Urocortin 2 and its fragments in mice","volume":"1680","author":"Bagosi","year":"2018","journal-title":"Brain Res."},{"issue":"28","key":"10.1016\/j.pbb.2018.11.009_bb0010","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1523\/JNEUROSCI.0563-04.2004","article-title":"Variability in the benzodiazepine response of serotonin 5-HT1A receptor null mice displaying anxiety-like phenotype: evidence for genetic modifiers in the 5-HT-mediated regulation of GABAA receptors","volume":"24","author":"Bailey","year":"2004","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.pbb.2018.11.009_bb0015","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/BF00169129","article-title":"Piperazine derivatives including the putative anxiolytic drugs, buspirone and ipsapirone, are agonists at 5-HT1A receptors negatively coupled with adenylate cyclase in hippocampal neurons","volume":"335","author":"Bockaert","year":"1987","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.pbb.2018.11.009_bb0020","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0021-9673(01)88424-7","article-title":"Identification and quantitation of 1-(2-pyrimidinyl) piperazine, an active metabolite of the anxiolytic agent buspirone, in rat plasma and brain","volume":"252","author":"Caccia","year":"1982","journal-title":"J. Chromatogr. A"},{"issue":"7","key":"10.1016\/j.pbb.2018.11.009_bb0025","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/sj.bjp.0706796","article-title":"Mechanism of action of benzodiazepines on GABAA receptors","volume":"148","author":"Campo-Soria","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.pbb.2018.11.009_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0166-4328(01)00452-1","article-title":"Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice","volume":"134","author":"Carola","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2018.11.009_bb0035","series-title":"Guide to Research Techniques in Neuroscience","first-page":"39","article-title":"Chapter 2 \u2014 animal behavior","author":"Carter","year":"2015"},{"issue":"2","key":"10.1016\/j.pbb.2018.11.009_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/157015906776359540","article-title":"Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology","volume":"4","author":"Ciranna","year":"2006","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pbb.2018.11.009_bb0045","series-title":"Techniques in the Behavioral and Neural Sciences","first-page":"443","article-title":"Chapter 17 \u2014 conflict behaviors as animal models for the study of anxiety","author":"Commissaris","year":"1993"},{"issue":"1","key":"10.1016\/j.pbb.2018.11.009_bb0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0006-8993(02)02965-7","article-title":"Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests","volume":"949","author":"Degroot","year":"2002","journal-title":"Brain Res."},{"issue":"3\u20134","key":"10.1016\/j.pbb.2018.11.009_bb0055","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0091-3057(01)00541-X","article-title":"Septal GABAergic and hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests","volume":"69","author":"Degroot","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.pbb.2018.11.009_bb0060","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0022-3565(25)10249-8","article-title":"Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites","volume":"264","author":"Ernsberger","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.pbb.2018.11.009_bb0065","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1037\/0735-7044.112.2.352","article-title":"Endogenous acetylcholine in the dorsal hippocampus reduces anxiety through actions on nicotinic and muscarinic\u2081 receptors","volume":"112","author":"File","year":"1998","journal-title":"Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2018.11.009_bb0070","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0006-8993(81)90118-9","article-title":"Evidence for a tonic GABAergic control of serotonin neurons in the median raphe nucleus","volume":"206","author":"Forchetti","year":"1981","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2018.11.009_bb0075","first-page":"1","article-title":"Anxiolytic and antidepressant-like effects of the aqueous extract of Alafia multiflora stem barks in rodents","author":"Foyet","year":"2012","journal-title":"Adv. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.pbb.2018.11.009_bb0080","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10571-014-0035-z","article-title":"Asparagus racemosus attenuates anxiety-like behavior in experimental animal models","volume":"34","author":"Garabadu","year":"2014","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.pbb.2018.11.009_bb0085","series-title":"Comprehensive Medicinal Chemistry II","first-page":"85","article-title":"6.04 \u2014 anxiety","author":"Gogas","year":"2007"},{"issue":"3","key":"10.1016\/j.pbb.2018.11.009_bb0090","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/jnc.13398","article-title":"Modulation of GABA release from the thalamic reticular nucleus by cocaine and caffeine: role of serotonin receptors","volume":"136","author":"Goitia","year":"2016","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.pbb.2018.11.009_bb0095","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10571-012-9827-1","article-title":"Stress-related serotonergic systems: implications for symptomatology of anxiety and affective disorders","volume":"32","author":"Hale","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.pbb.2018.11.009_bb0100","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/npp.2008.71","article-title":"Stress impairs 5-HT 2A receptor-mediated serotonergic facilitation of GABA release in juvenile rat basolateral amygdala","volume":"34","author":"Jiang","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pbb.2018.11.009_bb0105","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.janxdis.2010.01.009","article-title":"Clinical characteristics of anxiety disordered youth","volume":"24","author":"Kendall","year":"2010","journal-title":"J. Anxiety Disord."},{"issue":"7","key":"10.1016\/j.pbb.2018.11.009_bb0110","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/j.1476-5381.1996.tb15304.x","article-title":"Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety","volume":"117","author":"Kennett","year":"1996","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2018.11.009_bb0115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1469-7793.2000.00373.x","article-title":"Presynaptic 5-HT3 receptor-mediated modulation of synaptic GABA release in the mechanically dissociated rat amygdala neurons","volume":"529","author":"Koyama","year":"2000","journal-title":"J. Physiol."},{"issue":"5A","key":"10.1016\/j.pbb.2018.11.009_bb4000","doi-asserted-by":"crossref","first-page":"L768","DOI":"10.1143\/JJAP.26.L768","article-title":"Effect of oxygen deficiency on the crystal structure and superconducting properties of the Ba2YCu3Oy","volume":"26","author":"Kubo","year":"1987","journal-title":"Jpn. J. Appl. Phys."},{"key":"10.1016\/j.pbb.2018.11.009_bb0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejmech.2018.02.078","article-title":"Development of piperazinediones as dual inhibitor for treatment of Alzheimer's disease","volume":"150","author":"Kumar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.pbb.2018.11.009_bb4005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.pbb.2018.11.009_bb0125","first-page":"549","article-title":"The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology","volume":"32","author":"Martin","year":"2009","journal-title":"Psychiatr. Clin."},{"issue":"1\u20132","key":"10.1016\/j.pbb.2018.11.009_bb0130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0006-8993(83)90203-2","article-title":"Evidence for a GABAergic inhibitory influence on serotonergic neurons originating from the dorsal raphe","volume":"279","author":"Nishikawa","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2018.11.009_bb0135","series-title":"Maps and Guide to Microdissection of the Rat Brain","author":"Palkovits","year":"1988"},{"key":"10.1016\/j.pbb.2018.11.009_bb0140","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bbr.2016.10.010","article-title":"Anxiolytic properties of N-acetylcysteine in mice","volume":"317","author":"Santos","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2018.11.009_bb0145","article-title":"Use of the open field maze to measure locomotor and anxiety-like behavior in mice","volume":"96","author":"Seibenhener","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.pbb.2018.11.009_bb0150","series-title":"1-Substituted-4-(thiazolyl-2-)-piperazines, -Piperidines and -Tetrahydropyridines Useful as Anxiolytic, Psychogeriatric, Antidepressant and Antischizophrenic Agents","author":"Sorg","year":"1988"},{"issue":"S 3","key":"10.1016\/j.pbb.2018.11.009_bb0155","first-page":"207","article-title":"Stress responsive neurohormones in depression and anxiety","volume":"36","author":"Str\u00f6hle","year":"2003","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.pbb.2018.11.009_bb0160","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nprot.2007.44","article-title":"The use of the elevated plus maze as an assay of anxiety-related behavior in rodents","volume":"2","author":"Walf","year":"2007","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.pbb.2018.11.009_bb0165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/1472-6882-12-223","article-title":"Evaluation of anxiolytic activity of compound Valeriana jatamansi Jones in mice","volume":"12","author":"You","year":"2012","journal-title":"BMC Complement. Altern. Med."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305718304660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305718304660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:34:15Z","timestamp":1758774855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305718304660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":35,"alternative-id":["S0091305718304660"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2018.11.009","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological profiling of piperazinediones for the management of anxiety","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2018.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}